Filing Details

Accession Number:
0001209191-17-008304
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-07 16:11:22
Reporting Period:
2017-02-06
Filing Date:
2017-02-07
Accepted Time:
2017-02-07 16:11:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1123494 Harvard Bioscience Inc HBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008643 David Green 84 October Hill Road
Holliston MA 01746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-06 1,288 $3.25 928,810 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 234,896 Indirect David Green 2015-1 Annuity Trust
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2016.
  2. Includes (a) a deferred stock award of 12,600 restricted stock units which vest quarterly in equal installments on March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017; (b) a deferred stock award of 25,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 1, 2016, immediately prior to the commencement of such meeting, and (ii) July 1, 2017; and (c) 890,910 shares of common stock held by the Reporting Person.